CN Stock MarketDetailed Quotes
688166 Brightgene Bio-Medical Technology Co.,Ltd.
- 33.20
- -0.60-1.78%
Market Closed Dec 13 15:00 CST
14.03BMarket Cap74.61P/E (TTM)
33.48High32.13Low122.45KlotVolume33.22Open33.80Pre Close400.65MTurnover2.90%Turnover Ratio69.31P/E (Static)422.47MShares41.3952wk High6.16P/B14.03BFloat Cap19.5352wk Low40.56Limit Up422.47MShs Float72.02Historical High27.04Limit Down3.99%Amplitude16.89Historical Low0.10Dividend TTM32.72Avg Price67.15KlotAsk0.29%Div YieldTTM100Lot Size49.90KlotBid
Brightgene Bio-Medical Technology Co.,Ltd. Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||
| Goods sale service render cash | 19.36%813.79M | 30.32%573.59M | 32.23%336.34M | -9.19%975.8M | -17.32%681.77M | -11.36%440.15M | 22.85%254.36M | 23.16%1.07B | 28.36%824.62M | 36.94%496.58M |
| Refunds of taxes and levies | 50.02%48.81M | 51.83%30.51M | 39.72%19.23M | -43.02%44.7M | -56.88%32.54M | -54.39%20.1M | 1.28%13.76M | 69.30%78.45M | 132.47%75.47M | 92.02%44.07M |
| Cash received relating to other operating activities | -23.92%41.42M | 113.14%35.29M | 268.20%20.16M | 98.84%55.39M | 145.90%54.44M | 25.93%16.56M | 94.34%5.47M | 312.45%27.86M | 313.08%22.14M | 168.11%13.15M |
| Cash inflows from operating activities | 17.60%904.02M | 34.10%639.4M | 37.33%375.72M | -8.89%1.08B | -16.64%768.75M | -13.90%476.8M | 22.44%273.6M | 27.59%1.18B | 35.57%922.22M | 41.82%553.8M |
| Goods services cash paid | 35.31%286.21M | 0.84%137.92M | -6.82%69.55M | -6.42%318.85M | -37.19%211.51M | -46.44%136.77M | -32.44%74.64M | -4.24%340.73M | 8.79%336.73M | 37.35%255.36M |
| Staff behalf paid | 8.89%204.66M | 9.45%146.89M | -13.70%67.01M | 14.45%240.77M | 18.02%187.94M | 19.31%134.21M | 22.24%77.65M | 24.18%210.37M | 28.60%159.25M | 31.58%112.49M |
| All taxes paid | 21.76%67.14M | 3.95%43.25M | -9.20%20.43M | 20.68%74.11M | 12.89%55.14M | 41.78%41.61M | 19.91%22.5M | 56.85%61.42M | 77.93%48.84M | 67.40%29.35M |
| Cash paid relating to other operating activities | 5.16%226.43M | 42.39%160.12M | -4.72%70.27M | -3.78%247.38M | 25.51%215.32M | -0.38%112.45M | 22.23%73.75M | 38.89%257.1M | 25.33%171.56M | 27.18%112.87M |
| Cash outflows from operating activities | 17.09%784.43M | 14.85%488.18M | -8.56%227.26M | 1.32%881.12M | -6.49%669.92M | -16.67%425.04M | -1.80%248.54M | 16.03%869.62M | 19.86%716.38M | 35.05%510.08M |
| Net cash flows from operating activities | 21.01%119.59M | 192.14%151.22M | 492.42%148.46M | -37.43%194.77M | -51.99%98.83M | 18.39%51.76M | 184.52%25.06M | 76.78%311.26M | 149.28%205.84M | 241.69%43.72M |
| Investing cash flow | ||||||||||
| Cash received from disposal of investments | 23.50%61.75M | --51.17M | ---- | -82.78%102.16M | -90.86%50M | --0 | -80.72%13.5M | 89.52%593.09M | 76.40%546.86M | 46.15%380M |
| Cash received from returns on investments | -98.42%33.04K | --0 | ---- | -97.58%442.21K | -4.09%2.1M | -67.99%442.21K | ---- | -2.18%18.24M | 4.39%2.18M | -1.19%1.38M |
| Net cash received from disposal of fix assets、 intangible assets 、other long-term asset | --0 | ---- | ---- | 26.92%482.07K | -68.14%104.07K | ---- | ---- | 736.27%379.82K | 154.03%326.68K | -69.31%6.68K |
| Cash received relating to other investing activities | --36.5M | --36.5M | ---- | --30.82M | --0 | --0 | ---- | ---- | ---- | ---- |
| Cash inflows from investing activities | 88.28%98.28M | 19,725.26%87.67M | ---- | -78.11%133.9M | -90.50%52.2M | -99.88%442.21K | -80.79%13.5M | 84.45%611.7M | 75.95%549.37M | 45.89%381.39M |
| Cash paid to acquire fixed assets intangible assets and other long-term assets | -16.40%251.05M | -14.50%191.65M | -23.91%118.77M | -44.44%403.76M | -52.91%300.32M | -52.39%224.16M | -54.27%156.1M | -20.11%726.73M | -10.78%637.72M | -7.47%470.83M |
| Cash paid to acquire investments | 135.38%272.1M | 62.42%187.76M | -79.70%19.61M | -77.71%166.4M | -83.62%115.6M | -80.03%115.6M | -74.05%96.6M | 145.30%746.47M | 174.45%705.62M | 204.79%578.76M |
| Net cash paid to acquire subsidiaries and other business units | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -100.13%-9.95K | ---- | ---- |
| Cash paid relating to other investing activities | --0 | --0 | ---- | -64.37%3.6M | --3.87M | --3.87M | ---- | --10.09M | ---- | --0 |
| Cash outflows from investing activities | 24.62%523.15M | 10.41%379.42M | -45.24%138.38M | -61.32%573.76M | -68.75%419.79M | -67.26%343.63M | -64.59%252.7M | 21.43%1.48B | 38.22%1.34B | 50.21%1.05B |
| Net cash flows from investing activities | -15.58%-424.87M | 14.99%-291.75M | 42.15%-138.38M | 49.53%-439.85M | 53.70%-367.59M | 48.64%-343.19M | 62.82%-239.2M | 2.05%-871.58M | -20.36%-793.96M | -52.80%-668.21M |
| Financing cash flow | ||||||||||
| Cash received from capital contributions | --0 | --0 | ---- | -76.78%68M | -0.02%60M | -0.02%60M | --60M | 237.73%292.81M | 795.67%60.01M | --60.01M |
| -Including: Cash received from capital contributions by minority shareholders of subsidiaries | --0 | --0 | ---- | -6.85%68M | -0.02%60M | -0.02%60M | --60M | -15.80%73M | 795.67%60.01M | --60.01M |
| Cash from borrowing | 6.56%595.96M | 53.05%516.06M | 96.95%262.95M | -58.80%678.23M | -57.60%559.28M | -72.55%337.19M | -83.85%133.51M | 86.59%1.65B | 85.39%1.32B | 195.55%1.23B |
| Cash inflows from financing activities | -3.76%595.96M | 29.93%516.06M | 35.88%262.95M | -61.51%746.23M | -55.09%619.28M | -69.17%397.19M | -76.59%193.51M | 100.11%1.94B | 92.02%1.38B | 209.99%1.29B |
| Borrowing repayment | 40.43%627.88M | 19.64%338.14M | 81.99%236.55M | 18.13%560.09M | 9.48%447.12M | -19.13%282.63M | -15.46%129.98M | 124.83%474.12M | 242.41%408.41M | 282.81%349.49M |
| Dividend interest payment | 18.25%118.86M | -51.34%43.76M | 264.86%29.56M | 14.90%115.01M | 15.72%100.51M | 24.45%89.93M | -5.41%8.1M | 84.34%100.1M | 89.48%86.86M | 99.51%72.26M |
| Cash payments relating to other financing activities | 363.37%22.99M | --18.47M | --7.81M | --9.52M | --4.96M | --0 | ---- | --0 | ---- | ---- |
| Cash outflows from financing activities | 39.29%769.73M | 7.46%400.37M | 98.37%273.92M | 19.23%684.62M | 11.57%552.59M | -11.66%372.56M | -14.93%138.08M | 116.54%574.22M | 199.95%495.27M | 230.74%421.76M |
| Net cash flows from financing activities | -360.58%-173.77M | 369.81%115.69M | -119.80%-10.97M | -95.49%61.61M | -92.45%66.68M | -97.16%24.63M | -91.66%55.42M | 93.92%1.36B | 59.80%883.78M | 200.80%866.62M |
| Net cash flow | ||||||||||
| Exchange rate change effecting cash and cash equivalents | 135.02%1.33M | 282.22%1.91M | 121.61%809.43K | -80.34%2.78M | -184.14%-3.81M | -226.81%-1.05M | -1,518.99%-3.75M | 280.19%14.15M | 138.02%4.53M | -121.41%-321.39K |
| Net increase in cash and cash equivalents | -132.03%-477.72M | 91.44%-22.92M | 99.95%-78.89K | -122.08%-180.69M | -168.59%-205.88M | -210.77%-267.85M | -1,756.58%-162.47M | 13,053.66%818.52M | 1,456.85%300.18M | 279.23%241.81M |
| Add:Begin period cash and cash equivalents | -15.69%971.04M | -15.69%971.04M | -15.69%971.04M | 245.64%1.15B | 245.64%1.15B | 245.64%1.15B | 245.64%1.15B | -1.86%333.21M | -1.86%333.21M | -1.86%333.21M |
| End period cash equivalent | -47.84%493.32M | 7.27%948.12M | -1.85%970.96M | -15.69%971.04M | 49.33%945.85M | 53.71%883.88M | 204.89%989.27M | 245.64%1.15B | 99.55%633.4M | 181.03%575.03M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
